Daylight Photodynamic Therapy: An Update

Chaw Ning Lee, Rosie Hsu, Hsuan Chen, Tak Wah Wong

Research output: Contribution to journalReview articlepeer-review

1 Citation (Scopus)

Abstract

Daylight photodynamic therapy (dPDT) uses sunlight as a light source to treat superficial skin cancer. Using sunlight as a therapeutic device has been present for centuries, forming the basis of photodynamic therapy in the 20th century. Compared to conventional PDT, dPDT can be a less painful, more convenient and an effective alternative. The first clinical uses of dPDT on skin cancers began in Copenhagen in 2008. Currently, aminolevulinic acid-mediated dPDT has been approved to treat actinic keratosis patients in Europe. In this review article, we introduce the history and mechanism of dPDT and focus on the pros and cons of dPDT in treating superficial skin cancers. The future applications of dPDT on other skin diseases are expected to expand as conventional PDT evolves.

Original languageEnglish
JournalMolecules (Basel, Switzerland)
Volume25
Issue number21
DOIs
Publication statusPublished - 2020 Nov 8

All Science Journal Classification (ASJC) codes

  • Analytical Chemistry
  • Chemistry (miscellaneous)
  • Molecular Medicine
  • Pharmaceutical Science
  • Drug Discovery
  • Physical and Theoretical Chemistry
  • Organic Chemistry

Fingerprint Dive into the research topics of 'Daylight Photodynamic Therapy: An Update'. Together they form a unique fingerprint.

Cite this